Delivery Order SPE2DB22D1106-SPE2DB23FESN4

Award Date 7/25/23
Potential Completion Date 7/26/23
Potential Value $12
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $571,000 to supply 1,000 boxes of 80mg atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol medication to a facility in Conshohocken, Pennsylvania under a one day period of performance beginning on August 15, 2023. The order is funded through the Defense Logistics Agency to support the Department of Defense's medical...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $42,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will supply 500 boxes containing 20 mg tablets of atorvastatin to be delivered from its facility in Conshohocken, Pennsylvania by July 24, 2023. The ordering agency, DLA, manages the Department of Defense's global supply chain and works to provide medical supplies and pharmaceuticals to support military readiness....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred and sixty-four dollars to Amerisourcebergen Drug Corporation for the supply of atorvastatin tablets. Under the contract, Amerisourcebergen will deliver four hundred and fifty-six thousand two hundred and three tablets of atorvastatin, an 80mg cholesterol-lowering medication, to a facility in Conshohocken, Pennsylvania within a performance period spanning September 1st through...
The Defense Logistics Agency awarded a $74,640 delivery order to Amerisourcebergen Drug Corporation for 80mg atorvastatin tablets. Under this firm fixed price contract, Amerisourcebergen will supply 90 tablets of the cholesterol-lowering drug to an unspecified customer, with performance taking place at its facility in Conshohocken, Pennsylvania between September 5-6, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the Department of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $369.53 to Amerisourcebergen Drug Corporation. Under this contract, Amerisourcebergen will supply the Defense Logistics Agency with 1,000 tablets of atorvastatin 40 mg, to be delivered from its facility in Conshohocken, Pennsylvania between July 20-21, 2023. As a top pharmaceutical supplier to the U.S. Government, Amerisourcebergen will provide this generic cholesterol medication to support the Defense Logistics...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred forty-two dollars and seventy cents to Amerisourcebergen Drug Corporation for the provision of five hundred tablets of atorvastatin 20 mg. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is limited to August 15 through August 16, 2023. As a top pharmaceutical supplier to the Department of Defense, Amerisourcebergen will deliver the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $80,920 to Amerisourcebergen Drug Corporation. The order is for 1,000 tablets of the cholesterol-lowering drug atorvastatin 40 mg to be delivered to a facility in Conshohocken, Pennsylvania by August 29, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency is the funding agency for this order to...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $526 to Amerisourcebergen Drug Corporation. The order is for 1000 tablets of the cholesterol medication atorvastatin 40 mg to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this delivery issued against an existing DLA contract vehicle. No set...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $24,880 to Amerisourcebergen Drug Corporation for atorvastatin 80 mg tablets. Under the contract, Amerisourcebergen will deliver 90 boxes of the generic cholesterol medication to a facility in Conshohocken, Pennsylvania, with performance required from August 2-3, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will support the Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand dollars to Amerisourcebergen Drug Corporation for atorvastatin 20 mg tablets. Under the contract, Amerisourcebergen will deliver 500 strips of the generic cholesterol medication to a facility in Conshohocken, Pennsylvania by September 14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB23FESN4
    Delivery Order

The Defense Logistics Agency awarded a $12,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 80mg atorvastatin tablets. Under this order, Amerisourcebergen will deliver 90 tablets of the cholesterol-lowering drug to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of the Department of Defense's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders under the DLA's Pharmaceutical Prime Vendor contract to provide prescription drugs and other medical supplies to military treatment facilities worldwide. No subcontractors or set aside designations were indicated in the award information.

Generated 12/18/23, 7:07 PM